/4886.T
4886.T Stock - ASKA Pharmaceutical Holdings Co.,Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericJPX
$2064.00+2.03%
+$41.00 (+2.03%) • Dec 23
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.38
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2270.40
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4886.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2043.36 – $2084.64
TARGET (TP)$2373.60
STOP LOSS$1898.88
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.13
52W High$2942.00
52W Low$1825.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $64.14B | $62.84B | $60.46B | $56.61B | $55.18B |
| Gross Profit | $31.34B | $30.66B | $28.59B | $26.35B | $25.38B |
| Gross Margin | 48.9% | 48.8% | 47.3% | 46.6% | 46.0% |
| Operating Income | $5.33B | $6.50B | $5.11B | $4.79B | $3.61B |
| Net Income | $5.10B | $7.54B | $4.24B | $4.29B | $2.71B |
| Net Margin | 8.0% | 12.0% | 7.0% | 7.6% | 4.9% |
| EPS | $179.94 | $266.49 | $150.08 | $151.22 | $95.63 |
Company Overview
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4886.TBeat Rate
100%
Last 1 quarters
Avg Surprise
+2.6%
EPS vs Estimate
Beats / Misses
1/0
Last 12 quarters
Latest EPS
$34.60
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
+2.6%
$44.94vs$43.80
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 4, 2025 | — | $34.60 | — | — |
Q3 2025 | Aug 4, 2025 | — | $43.89 | — | — |
Q2 2025 | May 12, 2025 | — | $35.36 | — | — |
Q1 2025 | Feb 3, 2025 | — | $54.23 | — | — |
Q4 2024 | Nov 5, 2024 | — | $45.41 | — | — |
Q3 2024 | Aug 5, 2024 | $43.80 | $44.94 | +2.6% | ✓ BEAT |
Q2 2024 | May 10, 2024 | — | $38.37 | — | — |
Q1 2024 | Feb 5, 2024 | — | $82.22 | — | — |
Q4 2023 | Nov 6, 2023 | — | $95.40 | — | — |
Q3 2023 | Aug 7, 2023 | — | $50.48 | — | — |
Q2 2023 | May 11, 2023 | — | $1.95 | — | — |
Q1 2023 | Feb 6, 2023 | — | $65.00 | — | — |
Q4 2022 | Nov 7, 2022 | — | $36.24 | — | — |
Q3 2022 | Aug 8, 2022 | — | $46.94 | — | — |
Q2 2022 | May 12, 2022 | — | $7.35 | — | — |
Q1 2022 | Feb 7, 2022 | — | $242.07 | — | — |
Q4 2021 | Nov 1, 2021 | — | $-137.11 | — | — |
Q3 2021 | Aug 2, 2021 | — | $38.69 | — | — |
Q2 2021 | May 11, 2021 | — | $9.23 | — | — |
Q1 2021 | Feb 1, 2021 | — | $31.70 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4886.T
What is 4886.T's current stock price?
ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) is currently trading at $2064.00 per share. The stock has moved +2.03% today.
What is the analyst price target for 4886.T?
No analyst price targets are currently available for this stock.
What sector is ASKA Pharmaceutical Holdings Co.,Ltd. in?
ASKA Pharmaceutical Holdings Co.,Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the JPX exchange.
What is 4886.T's market cap?
ASKA Pharmaceutical Holdings Co.,Ltd. has a market capitalization of $58.55 billion, making it a large-cap company.
Does 4886.T pay dividends?
No, ASKA Pharmaceutical Holdings Co.,Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector197A.T
TAUNS Laboratories, Inc.
$524.00
Mkt Cap: $54.1B
2395.T
Shin Nippon Biomedical Laboratories, Ltd.
$1794.00
Mkt Cap: $74.7B
2664.T
Cawachi Limited
$2980.00
Mkt Cap: $66.6B
3151.T
Vital KSK Holdings, Inc.
$1376.00
Mkt Cap: $66.6B
368A.T
Kitazato Corporation
$1565.00
Mkt Cap: $62.6B
4554.T
Fuji Pharma Co., Ltd.
$1901.00
Mkt Cap: $46.4B
4569.T
KYORIN Holdings, Inc.
$1547.00
Mkt Cap: $88.9B
4820.T
EM Systems Co., Ltd.
$814.00
Mkt Cap: $56.3B
5889.T
Japan Eyewear Holdings Co., Ltd.
$1992.00
Mkt Cap: $48.1B
7979.T
Shofu Inc.
$1835.00
Mkt Cap: $65.2B
Explore stocks similar to 4886.T for comparison